Revvity Comprehensive Income 2010-2024 | RVTY
Revvity comprehensive income from 2010 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
- Revvity comprehensive income for the quarter ending June 30, 2024 was $-0.342B, a 12.12% increase year-over-year.
- Revvity comprehensive income for 2023 was $-0.277B, a 38.17% decline from 2022.
- Revvity comprehensive income for 2022 was $-0.447B, a 175.06% increase from 2021.
- Revvity comprehensive income for 2021 was $-0.163B, a 409.03% increase from 2020.
| Revvity Annual Comprehensive Income (Millions of US $) |
|
|---|---|
| 2023 | $-277 |
| 2022 | $-447 |
| 2021 | $-163 |
| 2020 | $-32 |
| 2019 | $-200 |
| 2018 | $-176 |
| 2017 | $-47 |
| 2016 | $-101 |
| 2015 | $-46 |
| 2014 | $25 |
| 2013 | $78 |
| 2012 | $67 |
| 2011 | $54 |
| 2010 | $51 |
| 2009 | $-27 |
| Revvity Quarterly Comprehensive Income (Millions of US $) |
|
|---|---|
| 2024-06-30 | $-342 |
| 2024-03-31 | $-325 |
| 2023-12-31 | $-277 |
| 2023-09-30 | $-379 |
| 2023-06-30 | $-305 |
| 2023-03-31 | $-304 |
| 2022-12-31 | $-447 |
| 2022-09-30 | $-650 |
| 2022-06-30 | $-459 |
| 2022-03-31 | $-247 |
| 2021-12-31 | $-163 |
| 2021-09-30 | $-146 |
| 2021-06-30 | $-92 |
| 2021-03-31 | $-104 |
| 2020-12-31 | $-32 |
| 2020-09-30 | $-144 |
| 2020-06-30 | $-217 |
| 2020-03-31 | $-278 |
| 2019-12-31 | $-200 |
| 2019-09-30 | $-243 |
| 2019-06-30 | $-181 |
| 2019-03-31 | $-174 |
| 2018-12-31 | $-176 |
| 2018-09-30 | $-161 |
| 2018-06-30 | $-131 |
| 2018-03-31 | $-28 |
| 2017-12-31 | $-47 |
| 2017-09-30 | $-54 |
| 2017-06-30 | $-63 |
| 2017-03-31 | $-82 |
| 2016-12-31 | $-101 |
| 2016-09-30 | $-55 |
| 2016-06-30 | $-45 |
| 2016-03-31 | $-14 |
| 2015-12-31 | $-46 |
| 2015-09-30 | $-33 |
| 2015-06-30 | $13 |
| 2015-03-31 | $1 |
| 2014-12-31 | $25 |
| 2014-09-30 | $48 |
| 2014-06-30 | $81 |
| 2014-03-31 | $78 |
| 2013-12-31 | $78 |
| 2013-09-30 | $69 |
| 2013-06-30 | $52 |
| 2013-03-31 | $53 |
| 2012-12-31 | $67 |
| 2012-09-30 | $59 |
| 2012-06-30 | $38 |
| 2012-03-31 | $68 |
| 2011-12-31 | $54 |
| 2011-09-30 | $-31 |
| 2011-06-30 | $10 |
| 2011-03-31 | $-6 |
| 2010-12-31 | $51 |
| 2010-09-30 | $-45 |
| 2010-06-30 | $-98 |
| 2010-03-31 | $-56 |
| 2009-12-31 | $-27 |
| 2009-09-30 | $-16 |
| 2009-06-30 | $-37 |
| 2009-03-31 | $-79 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $15.367B | $2.751B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $125.093B | 15.25 |
| Cencora (COR) | United States | $45.021B | 17.20 |
| ICON (ICLR) | Ireland | $24.951B | 22.42 |
| DiDi Global (DIDIY) | China | $18.956B | 0.00 |
| Avantor (AVTR) | United States | $18.396B | 27.90 |
| Natera (NTRA) | United States | $15.720B | 0.00 |
| Viatris (VTRS) | United States | $14.203B | 4.33 |
| CochLear (CHEOY) | Australia | $12.751B | 0.00 |
| Solventum (SOLV) | United States | $12.458B | 0.00 |
| Medpace Holdings (MEDP) | United States | $11.201B | 33.99 |
| Charles River Laboratories (CRL) | United States | $10.641B | 20.11 |
| Sonic Healthcare (SKHHY) | Australia | $8.811B | 0.00 |
| Doximity (DOCS) | United States | $7.438B | 47.13 |
| Bausch + Lomb (BLCO) | Canada | $7.041B | 30.30 |
| HealthEquity (HQY) | United States | $6.771B | 36.75 |
| PACS (PACS) | United States | $6.218B | 0.00 |
| Organon (OGN) | United States | $5.142B | 5.23 |
| Life Times (LTH) | United States | $4.879B | 40.78 |
| Sotera Health (SHC) | United States | $4.741B | 23.91 |
| Surgery Partners (SGRY) | United States | $4.088B | 45.30 |
| Concentras Parent (CON) | United States | $2.955B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $2.789B | 105.00 |
| BrightSpring Health Services (BTSG) | United States | $2.550B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.438B | 0.00 |
| Progyny (PGNY) | United States | $2.206B | 38.79 |
| Alignment Healthcare (ALHC) | United States | $2.177B | 0.00 |
| Premier (PINC) | United States | $2.052B | 9.23 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.921B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.778B | 8.93 |
| Agilon Health (AGL) | United States | $1.642B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.556B | 0.00 |
| CareDx (CDNA) | United States | $1.543B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.183B | 0.00 | |
| GeneDx Holdings (WGS) | United States | $1.044B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.933B | 24.43 |
| Pediatrix Medical (MD) | United States | $0.933B | 10.15 |
| Embecta (EMBC) | United States | $0.895B | 5.97 |
| InnovAge Holding (INNV) | United States | $0.812B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.551B | 0.00 |
| Sharecare (SHCR) | United States | $0.527B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.499B | 0.00 |
| Enhabit (EHAB) | United States | $0.410B | 35.48 |
| Sonida Senior Living (SNDA) | United States | $0.370B | 0.00 |
| DocGo (DCGO) | United States | $0.361B | 13.58 |
| Sera Prognostics (SERA) | United States | $0.261B | 0.00 |
| Biodesix (BDSX) | United States | $0.253B | 0.00 |
| LifeMD (LFMD) | United States | $0.226B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.194B | 0.00 |
| ModivCare (MODV) | United States | $0.192B | 6.11 |
| Beauty Health (SKIN) | United States | $0.187B | 0.00 |
| MultiPlan (MPLN) | United States | $0.152B | 0.00 |
| Nutex Health (NUTX) | United States | $0.126B | 0.00 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.083B | 0.00 |
| So-Young (SY) | China | $0.081B | 19.72 |
| Singular Genomics Systems (OMIC) | United States | $0.042B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 1.66 |
| Co-Diagnostics (CODX) | United States | $0.041B | 0.00 |
| OncoCyte (OCX) | United States | $0.039B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.030B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.028B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.026B | 0.00 |
| Oncology Institute (TOI) | United States | $0.023B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.021B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.010B | 0.00 |
| KindlyMD (KDLY) | $0.008B | 0.00 | |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |